Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Oligoprogression After Immunotherapy and Targeted Therapy in Metastatic Melanoma.

Oncology (Williston Park, N.Y.) - 16 Sept 2021

Sobrevilla-Moreno Nora, Rivera-Sánchez Daniel, García-Ortega Dorian, López-Macías Diego, Garcilazo-Reyes Alexandra, Álvarez-Avitia Miguel

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immunotherapy
Share to Melanoma
Share to Molecular Targeted Therapy
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Metastasis

Share to Proto-Oncogene Proteins B-raf

Share to Skin Neoplasms

Source

Identifiers

PMID: 34529396
DOI: 10.46883/ONC.2021.3509.0562

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Oligoprogression After Immunotherapy and Targeted Therapy in Metastatic Melanoma.PMID 34529396Read ↗

Has targeted therapy for melanoma made chemotherapy obsolete?Semantic proximity Read ↗

Peripheral CD8+ T cell characteristics associated with durable responses to immune checkpoint blockade in patients with metastatic melanomaSemantic proximity Read ↗

Long-term clinical outcome of melanoma patients treated with messenger RNA-electroporated dendritic cell therapy following complete resection of metastasesSemantic proximity Read ↗

Adoptive TIL transfer in the adjuvant setting for melanoma: long-term patient survival.Semantic proximity Read ↗

Hyperprogressors after Immunotherapy: Analysis of Genomic Alterations Associated with Accelerated Growth RateSemantic proximity Read ↗

Nivolumab (Opdivo) plus ipilimumab (Yervoy) for metastatic melanoma.Semantic proximity Read ↗

Recent Progress in Mutation-driven Therapy, Immunotherapy and Combination Therapy for the Treatment of Melanoma.Semantic proximity Read ↗

Therapy of metastatic malignant melanoma: on the way to individualized disease control.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.